Intervertebral disc degeneration is a common cause of discogenic low back pain resulting in
significant disability. Current conservative or surgical intervention treatments do not reverse …

Intervertebral disc degeneration (IDD) is a common and early-onset pathogenesis in the
human lifespan that can increase the risk of low back pain. More clarification of the …

Exosome therapy is a promising therapeutic approach for intervertebral disc degeneration
(IVDD) and achieves its therapeutic effects by regulating metabolic disorders, the …

Lower back pain (LBP) occurs in 80% of adults in their lifetime; resulting in LBP being one of
the biggest causes of disability worldwide. Chronic LBP has been linked to the degeneration …

Chronic low back pain and dyskinesia caused by intervertebral disc degeneration (IDD) are
seriously aggravated and become more prevalent with age. Current clinical treatments do …

Chronic low back pain is the number one cause of years lived with disability. In about 40% of
patients, chronic lower back pain is related to intervertebral disc (IVD) degeneration. The …

Low back pain represents the highest burden of musculoskeletal diseases worldwide and
intervertebral disc degeneration is frequently associated with this painful condition. Even …

Introduction: As many as 80% of the adult population experience back pain at some point in
their lifetimes. Previous studies have indicated a link between back pain and intervertebral …

Intervertebral disc degeneration (IDD) is a prevalent musculoskeletal degenerative disorder
worldwide, and~ 40% of chronic low back pain cases are associated with IDD. Although the …

Stem cell-based tissue engineering is a promising treatment for intervertebral disc (IVD)
degeneration. A bio-scaffold that can maintain the function of transplanted cells and …